Table 5.
TLR4 gene polymorphism | Alleles | |||||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Groups | CagA status | TT | CT | CC | Total | C | T | p |
PU | CagA+ | 53 (75.7%) | 13 (18.6%) | 4 (5.7%) | 70 (100.0%) | 119 (85.0%) | 21 (15.0%) | *0.847 |
CagA- | 24 (80.0%) | 5 (16.7%) | 1 (3.3%) | 30 (100.0%) | 53 (88.3%) | 7 (11.7%) | **0.535 | |
Total | 77 (77.0%) | 18 (18.0%) | 5 (5.0%) | 100 (100.0%) | 172 (86.0%) | 118 (59.0%) | ||
AS | CagA+ | 63 (82.9%) | 9 (11.8%) | 4 (5.3%) | 76 (100.0%) | 135 (88.8%) | 17 (11.2%) | *0.975 |
CagA- | 40 (81.6%) | 6 (12.2%) | 3 (6.1%) | 49 (100.0%) | 86 (87.75%) | 12 (12.25%) | **0.798 | |
Total | 103 (82.4%) | 15 (12.0%) | 7 (5.6%) | 125 (100.0%) | 221 (88.4%) | 29 (11.6%) | ||
NHS | 95 (76.5%) | 25 (20.0%) | 5 (4.0%) | 125 (100.0%) | 215 (86.0%) | 35 (14.0%) |
comparison of the genotypes and alleles distribution at SNP rs4986790 between subjects infected with the CagA+ strains of H. pylori and those infected with CagA- strains of bacteria in specified group
AS: asymptomatic subjects; CagA: cytotoxin-associated gene A; NHS: non-infected healthy subjects; PU: peptic ulcer; SNP: single nucleotide polymorphism; TLR: Toll-like receptors